# Correction to “Higher Prevalence of Dupilumab‐Induced Ocular Adverse Events in Atopic Dermatitis Compared to Asthma: A Daily Practice Analysis”

PMC · DOI: 10.1002/clt2.70154 · 2026-02-16

## Full-text entities

- **Diseases:** SA (MESH:D013615), AD (MESH:D000544), Asthma (MESH:D001249), Atopic Dermatitis (MESH:D003876), Allergy (MESH:D004342)
- **Chemicals:** Dupilumab (MESH:C582203)
- **Species:** Homo sapiens (human, species) [taxon 9606]

---
Source: https://tomesphere.com/paper/PMC12909095